Learn how to maintain long-term health after switching to generic drugs, including the risks of NTI medications, manufacturer variances, and a 4-step safety protocol.
Read more
Narrow therapeutic index drugs require stricter bioequivalence standards to ensure patient safety. Learn how the FDA, EMA, and Health Canada differ in their rules, why generics are harder to make, and what this means for your treatment.
Read more